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https://doi.org/10.1016/j.stemcr.2019.04.009SUMMARYOculomotor neurons, which regulate eyemovement, are resilient to degeneration in the lethalmotor neuron disease amyotrophic lateral
sclerosis (ALS). It would be highly advantageous if motor neuron resilience could be modeled in vitro. Toward this goal, we generated a
high proportion of oculomotor neurons from mouse embryonic stem cells through temporal overexpression of PHOX2A in neuronal
progenitors. We demonstrate, using electrophysiology, immunocytochemistry, and RNA sequencing, that in vitro-generated neurons
are bona fide oculomotor neurons based on their cellular properties and similarity to their in vivo counterpart in rodent and man. We
also show that in vitro-generated oculomotor neurons display a robust activation of survival-promoting Akt signaling and are more resil-
ient to the ALS-like toxicity of kainic acid than spinal motor neurons. Thus, we can generate bona fide oculomotor neurons in vitro that
display a resilience similar to that seen in vivo.INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is characterized by a
loss of motor neurons in cortex, brain stem, and spinal
cord with subsequent spasticity, muscle atrophy, and paral-
ysis. Motor neurons innervating the extraocular muscles,
including the oculomotor, trochlear, and abducens nuclei,
are however relatively resistant to degeneration in ALS
(Comley et al., 2016; Gizzi et al., 1992; Nijssen et al.,
2017; Nimchinsky et al., 2000). This resilience has been
attributed to cell-intrinsic properties (Allodi et al., 2016;
Brockington et al., 2013; Comley et al., 2015; Hedlund
et al., 2010; Kaplan et al., 2014). It would be highly advan-
tageous if differential motor neuron vulnerability could
be modeled in vitro. This could aid in the identification
of gene targets responsible for oculomotor neuron resil-
ience. However, it is not self-evident that in vitro-generated
oculomotor neurons would be more resistant to degenera-
tion in culture than spinal motor neurons, as multiple
cell types contribute to motor neuron degeneration in
ALS, including, for example, astrocytes (Yamanaka et al.,
2008), microglia (Boillee et al., 2006), and oligodendro-
cytes (Kang et al., 2013), and may play a role in selective
vulnerability.
During development, distinct neuronal populations are
defined through diffusible morphogens with restricted tem-
poral and spatial patterns and subsequent activation of
distinct intrinsic transcription factor programs. These pro-
grams can be mimicked to specify different CNS regions
and neuronal populations from stem cells in vitro. When
mouse embryonic stem cells (mESCs) are exposed to SHH
(sonic hedgehog) signaling and retinoic acid,which ventral-
ize and caudalize the CNS during development, spinalStem Cell Rep
This is an open access artimotor neurons constitute 15%–30% of the cells in culture,
and interneurons the large remainder (Allodi and Hedlund,
2014; Wichterle et al., 2002). Oculomotor neurons consti-
tute only about 1% of the cells in the midbrain; thus,
patterning mESC cultures with fibroblast growth factor 8
(FGF8) and SHH to direct cultures toward a midbrain/hind-
brain fate (Allodi and Hedlund, 2014; Hedlund et al., 2008)
results in cultureswith too few oculomotor neurons to allow
for any quantitative analysis. However, when combining
morphogens with overexpression of the intrinsic determi-
nant Phox2a in neural precursors, a large proportion of
ISLET1/2+ brain stem motor neurons can be generated
(Mong et al., 2014). Furthermore, a combination of the tran-
scription factors Ngn2, Isl1, and Phox2a can specify mESCs
into cranial motor neurons (Mazzoni et al., 2013). However,
the exact identity of motor neurons generated this way has
not been previously demonstrated, and it is currently un-
clear whether these are indeed oculomotor neurons or
rather a mix of brain stem motor neurons, including, for
example, trigeminal and facial motor neurons.
Toward the goal of developing stem cell-based in vitro
models of differential vulnerability we generated cultures
with a high proportion of oculomotor neurons through
temporal overexpression of PHOX2A in mESC-derived
neuronal progenitors and compared these with mESC-
derived spinal motor neurons. Careful characterization of
these distinctmotor neuron populations using immunocy-
tochemistry, electrophysiological recordings, and RNA
sequencing demonstrated that mESC-derived oculomotor
neurons were highly similar to their in vivo counterparts
in both rodent and man. Finally, we exposed these to
ALS-like conditions using kainic acid and demonstrated
that oculomotor neurons were more resilient than spinalorts j Vol. 12 j 1329–1341 j June 11, 2019 j ª 2019 The Author(s). 1329
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
(legend on next page)
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motor neurons. Thus, we can generate bona fide oculomo-
tor neurons in vitro that display a resilience to ALS similar to
that seen in vivo.RESULTS
Bona Fide Oculomotor Neurons Can Be Generated
from mESCs
To characterize the specific identity of brain stem motor
neurons generated in culture and compare their properties
with those of spinal motor neurons, we generated neurons
frommESCs. Spinal motor neurons were derived by adding
100 nM retinoic acid and the smoothened agonist SAG to
the culture for 5 days. Brain stemmotor neurons were spec-
ified by overexpressing Phox2a under the nestin enhancer
and patterning the culture with FGF8 and SAG for 5 days
(Figure 1A). Immunocytochemical analysis demonstrated
that spinal motor neurons expressed the transcription fac-
tors ISLET1/2 and HB9 (MNX1) (64.1% ± 5.2% ISLET1/
2+HB9+ cells, mean ± SEM, n = 4) (Figures 1B, 1D, and
1E). PHOX2A-overexpressing motor neurons appeared to
be of an oculomotor identity as these cells expressed
ISLET1/2 but lacked HB9 (6.3% ± 1.3% ISLET1/2+HB9+
cells,mean ± SEM, n = 4), which is present in all cranialmo-
tor neuron nuclei except the oculomotor nucleus (Figures
1C, 1D, 1F, and 1G) (Guidato et al., 2003; Lance-Jones
et al., 2012). Henceforth we therefore refer to the brainFigure 1. PHOX2A Overexpression Drives the Generation of Bona
(A) Time line depicting in vitro protocols for the generation of resistan
(SC MN). The mESC column reports the four cell lines used in this study.
seq coupled with FACS was performed on EB dissociation day (day 9
dissociation (day 14 to 21).
(B and C) SC MNs generated from E14.1 ESCs express HB9, ISLET1, an
transcription factor Phox2a under the Nestin enhancer co-express ISL
(D) Percentage of HB9+/ISLET1+ cells in SC MN (64.1% ± 5.2%, mean
respectively (at least 120 Islet1+ cells counted per condition, bar an
(E) Microphotographs showing ISLET1+/TUJ1+ cells in OMN cultures.
(F) OMNs also express the specific marker PHOX2A as indicated by as
(G) Quantification of ISLET1+ over TUJ1+ cells demonstrates that ha
mean ± SEM, n = 4; total number of TUJ1+ cells counted: 1,325). Qu
in quadruplicates with two technical replicates each, total number of I
n = 4) of the ISLET1+ population is also PHOX2A+. All quantifications
conducted in quadruplicates including two technical replicates per e
(H) PCA of OMN and SC MN samples based on all genes expressed confi
MNs isolated by FACS was performed after 5 days of patterning (day 9
(I) A total of 1,017 DEGs was found between the two different cell t
significant DEGs by adjusted p value.
(J–L) Heatmap of expected progenitors and motor neuron transcript
generated motor neuron populations (J and L). Using the top 100 DEGs
originating from in vivo microarray studies on early postnatal (J) and
(M and N) Venn diagrams showing gene sets enriched either in brain st
gene sets preferentially found in spinal cord cultures or MN specific (stem motor neurons as oculomotor neurons. In oculomo-
tor neuron cultures 47.5% ± 5.9% (mean ± SEM, n = 4) of
bIII-TUBULIN+ cells were ISLET1/2+ and 62% ± 5.2%
(mean ± SEM, n = 4) of the ISLET1/2+ cells were PHOX2A+,
which demonstrates that 25% of all neurons generated
were oculomotor neurons (Figure 1G).
Oculomotor neurons (derived from Islet-GFP mESCs)
and spinal motor neurons (derived from Hb9-GFP mESCs)
were analyzed for their electrophysiological properties at
day-9 and day-11 time points (Figure S1). Cells were able
to fire overshooting action potentials in response to depo-
larizing current pulses. At day 9 few spikes were evoked.
Neuronal maturation from days 9 to 11 was seen as a
change in the electrical properties whereby day-11 oculo-
motor neurons could fire trains of action potentials (Figures
S1A and S1B) and the width of action potentials was
decreased when compared to day 9 (Figure S1C). The in-
crease in the size of neurons was reflected by the increased
cell capacity (Figure S1D), decreased input resistance (Fig-
ure S1E), and increased rheobase (Figure S1F) from days 9
to 11. Similar changes were seen in spinal motor neurons,
which fired a higher number of action potentials (Figures
S1G and S1H) and showed a reducedwidth of action poten-
tials (Figure S1I) at day 11 compared to day 9.Moreover, the
changes in cell capacity (Figure S1J), input resistance (Fig-
ure S1K), and rheobase (Figure S1L) showed signs of
neuronal maturation over time. To further investigate
neuronal maturation over time, we performed cholineFide Oculomotor Neurons from Stem Cells
t oculomotor neuron (OMN) and vulnerable spinal cord motor neuron
Patterning was performed for 5 days following EB formation. mRNA-
of the protocol). The survival assay was performed 5 days after EB
d NF200 (B). OMNs generated from E14.1 ESCs overexpressing the
ET1 and NF200 in the absence of HB9 (C). Scale bar, 60 mm.
± SEM, n = 4) and OMN (6.3% ± 1.3%, mean ± SEM, n = 4) cultures,
d whiskers represent means ± SEM).
terisks. Scale bar, 100 mm (applies also to E).
lf the neuronal population appears to be ISLET1+ (47.5% ± 5.9%,
antification of PHOX2A+ over ISLET1+ cells (experiments performed
slet1+ cells counted: 746) indicates that 62% ± 5.2% (mean ± SEM,
were performed 5 days after EB dissociation, and experiments were
xperiment (bar and whiskers represent means ± SEM).
rmed cell differential identities. mRNA-seq analysis of OMNs and SC
of the protocol).
ypes (adjusted p < 0.05, n = 6). Heatmap shows the top 500 most
s but also OMN and SC MN specific transcripts obtained in the two
obtained from our RNA-seq analysis (K), we could separate datasets
adult (L) rodent OMNs and SC MNs.
em cultures or OMN-specific as revealed by PAGODA analysis (M), and
N).
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acetyltransferase (ChAT) staining on oculomotor and spi-
nal motor neuron cultures, confirming expression of the
transferase from day 14 in vitro in both ISLET1+/HB9
and ISLET+/HB9+ cells (Figures S1M and S1N).
To further confirm the identity of the cells generated, we
sorted the motor neurons based on GFP expression using
fluorescence-activated cell sorting (FACS). For this purpose
we used a Hb9-GFP mESC line to select for spinal motor
neurons and an Islet-GFP:NesEPhox2a mESCs line for
the purification of oculomotor neurons (Figures 1A and
S2A–S2D). Poly(A)-based RNA sequencing of the sorted
fractions revealed a similar number of detected genes
for both lines (reads per kilobase per million mapped
reads [RPKM] >0.1: oculomotor neurons 13,941 ± 293.5
and spinal motor neurons 14,660.3 ± 304.1; RPKM >1:
oculomotor neurons 10,507 ± 296 and spinal motor neu-
rons 10,914.3 ± 362.7; mean ± SEM, t test for RPKM
>0.1 p = 0.1196, t test for RPKM >1 p = 0.4047; Figure S2E).
Sorted oculomotor neurons clustered closely together in
the principal component analysis (PCA) and were sepa-
rated from spinalmotor neurons along the fourth principal
component (Figure 1H). Hierarchical clustering of the
1,017 genes that were differentially expressed between oc-
ulomotor neurons and spinalmotor neurons at an adjusted
p value of <0.05 demonstrated that each group is defined
by a specific set of markers, with a majority of genes being
more highly expressed in spinal motor neurons (Figure 1I
and Table S1). Analysis of Hox mRNAs clearly demon-
strated the more caudal nature of spinal motor neurons
compared with oculomotor neurons (Figure S1F). The ocu-
lomotor neurons and spinal motor neurons clustered sepa-
rately based on known marker gene expression, e.g.,
Phox2a, Phox2b, Tbx20, and Rgs4 for oculomotor neurons
andOlig1/2,Hb9, and Lhx1/3 for spinalmotor neurons. Oc-
ulomotor neuron cultures were also devoid of noradren-
ergic neuron markers Slc6a2 (NET) and Th (Figure 1J).
Using the top 100 differentially expressed genes (DEGs)
between our in vitro-generated oculomotor neurons and
spinal motor neurons, we could separate a published mi-
croarray dataset (Mazzoni et al., 2013) of in vitro-generated
brain stem and spinal motor neurons (Figure S1G). Impor-
tantly, we could also use the 100 top DEGs between our oc-
ulomotor and spinal motor neurons to separate microarray
data originating frommouse oculomotor and spinal motor
neurons isolated from postnatal day 7 (P7) mice (Kaplan
et al., 2014) (Figure 1K) and from adult rats (Hedlund
et al., 2010) (Figure 1L). Thus, our in vitro-generated motor
neuron populations closely resemble their in vivo
counterparts.
To further delineate the nature of our in vitro culture
systems, we set out to identify gene clusters regulated
in groups of samples in an unbiased way. Here we
analyzed all GFP-positive (Hb9+ for spinal and Islet1+ for1332 Stem Cell Reports j Vol. 12 j 1329–1341 j June 11, 2019oculomotor) and -negative fractions from both spinal-
and midbrain-specified cultures using PAGODA (Fan
et al., 2016). This analysis revealed gene sets enriched in
the spinal and oculomotor cultures (GFP+ and GFP sam-
ples), as well as in the motor neuron groups specifically
(GFP+) (Figures 1M and 1N; Table S1). Of the oculomotor-
enriched genes found with DESeq2, a subset was enriched
in all midbrain-specified cultures (GFP+ and GFP cells),
such as Phox2a and Engrailed1 (En1). Fgf10, known to be
expressed in the developingmidbrain, including the oculo-
motor nucleus (Hattori et al., 1997), and Fgf15, with known
enrichment in midbrain and rhombomere 1 (Partanen,
2007), were also enriched in our midbrain-specified cul-
tures (Figure 1M). The genes that were highly enriched spe-
cifically in oculomotor neurons (GFP+) included Eya1,
Eya2, Tbx20, and Phox2b (Figure 1M). Vice versa, of the
genes found to be differentially expressed in spinal motor
neurons versus oculomotor neurons with DESeq2, a subset
was enriched in all samples of the spinal-specified cultures
versus the midbrain-specified cultures. This included Hox
genes that regulate positional identity, e.g., Hoxc4, Hoxd4,
Hoxa5, Hoxb5, Hoxb6, Hoxb8, and Hoxd8, as well as spinal
V1 interneuron markers Sp8 and Prdm8. Another subset
was found to be highly specific for only the spinal motor
neurons, including Mnx1 (Hb9) and Lhx1 (Figure 1N).
Different axon guidance-related genes are expressed by
oculomotor and spinal cord motor neurons during devel-
opment (Bjorke et al., 2016; Gutekunst and Gross, 2014;
Stark et al., 2015;Wang et al., 2011). To further characterize
the in vitro-generated oculomotor neurons, we analyzed
their mRNA expression of morphological markers that are
important for axon guidance. We found that oculomotor
neurons were enriched in Plxna4, Sema6d, Cdh6, and
Cdh12, while spinal motor neurons were enriched for
Epha3, Ephx4, Sema4a, and Sema5b (Figure S2G). We subse-
quently analyzed the expression level of these axon guid-
ance RNAs in microarray data from mouse oculomotor
and spinal motor neurons isolated from P7 mice (Kaplan
et al., 2014) and found that Sema6d was preferentially
maintained in oculomotor postnatally (Figure S2H).
Thus, our in vitro-generated oculomotor neurons
have characteristics distinct from spinal motor neurons
regarding genes that govern axon guidance, and some of
these characteristic are maintained in vivo.
In conclusion, we have generated a high proportion of
bona fide oculomotor neurons in vitro that can be utilized
to understand their normal function as well as resilience
to degeneration in motor neuron diseases.
StemCell-Derived Oculomotor Neurons Are Relatively
Resistant to Excitotoxicity
To investigate whether in vitro-generated oculomotor neu-
rons are relatively resistant to ALS-like toxicity similarly
Figure 2. In Vitro-Generated Oculomotor Neurons Are Relatively Resistant to ALS-like Toxicity
(A) OMNs and SC MNs express similar mRNA levels of glutamate ionotropic receptor AMPA, NMDA, and kainate type subunits. The heatmap
shows log2 RPKM values of these subunits, and no separate clustering of the two cell types is observed.
(B and C) Immunohistochemistry performed on generated OMNs (B) and SC MNs (C) at D1 in vitro in control conditions; similar levels of
glutamate ionotropic receptor kainate type subunit 5 (GRIK5) are found in both cell types. Scale bar in (C), 60 mm (applies also to B).
(D and E) Microphotographs presenting SC MN (D) and OMN (E) response to kainic acid-induced toxicity (20 mM) for a week. Scale bar in
(D), 100 mm (applies also to E).
(F) Curves represent percentages of MN survival over time in OMN and SC MN cultures. OMNs were visualized as NF200+ISLET1+HB9 cells,
while SC MNs as NF200+ISLET1+HB9+ cells. OMNs show increased survival to kainic acid toxicity at D7 (bar and whiskers represent
means ± SEM, two-way ANOVA and Tukey’s multiple comparison test, F(9, 56) = 2.333, *p = 0.0261, SC MNs n = 4, OMNs n = 5) when
compared with SC MNs (experiments were performed at least in quadruplicate, with technical replicates and with at least 130 motor
neurons counted per condition in each experiment).
(legend continued on next page)
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to their in vivo counterparts, we used kainic acid, which is a
neuroexcitatory amino acid that acts by activating gluta-
mate receptors. Glutamate excitotoxicity is thought to be
a downstream event in motor neuron degeneration in
ALS and is thus considered appropriate to model this dis-
ease. First, we evaluated the mRNA levels of glutamate ion-
otropic receptors in our cultures to ensure that generated
neurons could respond to kainic acid. mRNA-sequencing
data of sorted motor neurons demonstrated that oculomo-
tor neurons and spinal motor neurons expressed similar
levels of AMPA, NMDA, and kainate receptor subunits (Fig-
ure 2A). Grik5 (glutamate receptor, ionotrophic kainate 5)
was the subunit expressed at highest level (Figure 2A) and
was also detectable at the protein level in both oculomotor
(Figure 2B) and spinal (Figure 2C) motor neurons. Thus,
both motor neuron types should respond to kainic acid.
Exposure of the cultures to kainic acid for 1 week demon-
strated that oculomotor neurons were more resilient to
the elicited long-term excitotoxicity than spinal motor
neurons (ANOVA, *p < 0.05; Figures 2D–2F).
Stem cell-derived cultures are not easily temporally
restricted in a precise way. Cultures that contain postmi-
totic neurons may also harbor neuronal progenitors that
later on are specified into neurons. It can thus be chal-
lenging to distinguish survival from renewal in a stem
cell-based in vitro system. We therefore analyzed the turn-
over rate in our cultures by pulsing these with bromodeox-
yuridine (BrdU). Analysis of the number of BrdU+ISLET1/2+
neurons demonstrated that a significantly higher number
of motor neurons were generated over time in the spinal
motor neuron cultures compared with the oculomotor
neuron cultures (Figure S2I). Consequently, the resilience
of oculomotor neurons should be considered even more
pronounced as these cultures had a comparatively low
turnover rate. Furthermore, we investigated the presence
of astrocytes in the cultures and found that only aminority
of cells expressed glial fibrillary acidic protein (Figures S2J
and S2K). As the processes of motor neurons show the first
signs of pathology in ALS, we investigated length of
neuronal processes in both oculomotor and spinal motor
neuron cultures exposed to kainic acid for 7 days. The result(G) Analysis of the length of neuronal processes in both oculomotor
showed that oculomotor neurons were unaffected by kainic acid whil
whiskers represent means ± SEM, two-way ANOVA, *p < 0.05, n = 4).
(H–K) Sholl analysis was performed on OMN at D7 survival assay in
arborization complexity during toxicity. (H) Comparison of the aver
toxicity conditions with radial step size of 25 mm. OMNs did not show
multiple t test, n = 10). (I) Example of OMN at day 7 of KA20 toxicity. S
to individual OMNs after specifying the radius from the center of the
increasing radius. (K) Schematic depicting identification of neurite se
localization from the soma in an inside-out manner following the given
same color.
1334 Stem Cell Reports j Vol. 12 j 1329–1341 j June 11, 2019clearly demonstrated that oculomotor neurons were unaf-
fected by kainic acid while spinal motor neurons displayed
a shortening of neurites (Figure 2G). To further evaluate oc-
ulomotor neurites, we used Sholl analysis to interrogate
arborization complexity. The number and branching of oc-
ulomotor neurites were not negatively affected under
kainic acid treatment (Figures 2H–2K). As axonal fragmen-
tation and degeneration is seen early on in motor neurons
in ALS, our data clearly demonstrate that oculomotor neu-
rons cope well under conditions of excitotoxicity and
maintain normal morphology.
In conclusion, in vitro-generated oculomotor neurons are
highly resilient to ALS-like excitotoxicity. Thus, the pattern
of selective motor neuron vulnerability seen in vivo can be
replicated in vitro.
Oculomotor Neurons Have High Levels of Calcium-
Buffering Proteins and Akt Signaling, which Could
Contribute to Resilience
To explain the resilience of in vitro-generated oculomotor
neurons to excitotoxicity, we conducted a directed compar-
ative analysis of the RNA-sequencing data from purified oc-
ulomotor neurons versus spinalmotor neurons. It has been
suggested that preferential expression of calcium binding
proteins in oculomotor neurons plays a role in their resil-
ience (Comley et al., 2015; Van Den Bosch et al., 2002).
We focused on transcripts with implications in calcium
handling. Our analysis demonstrated that Cald1, Esyt1,
Camk2a, and Hpca11 were preferentially expressed in ocu-
lomotor neurons (Figure S3A). ESYT1 protein levels were
also preferential to oculomotor neurons and unaffected
by kainic acid treatment (Figures S3B–S3D). This could
render oculomotor neurons with an increased capacity to
buffer Ca2+ intracellularly.
We have previously shown that AKT signaling is impor-
tant in motor neuron resilience toward ALS after insulin-
like growth factor-2 treatment (Allodi et al., 2016). We
therefore analyzed our RNA-sequencing data from sorted
oculomotor and spinal motor neurons for Akt signaling ef-
fectors, which could aid in explaining the relative resilience
of oculomotor neurons in vitro. This analysis demonstratedand spinal motor neuron cultures exposed to kainic acid for 7 days
e spinal motor neurons displayed a shortening of neurites (bar and
control and KA20 conditions (H) to further assess individual MN
age number of neurite intersections of OMN in control and KA20
reduction in arborization (bar and whiskers represent means ± SEM,
cale bar in (I), 100 mm (applies also to J). (J) Sholl mask was applied
soma of the neuron and created concentric circles every 25 mm of
gments by Sholl analysis. Color code is assigned depending on arbor
radius. Multiple intersections within the same segment display the
Figure 3. mESC-Derived Oculomotor Neurons Have High Levels of Akt Signaling
(A) RPKM values from RNA sequencing of mESC-derived oculomotor and spinal motor neurons enriched by FACS shows preferential
expression of Akt1 and Akt3 transcripts in the generated OMNs (bar and whiskers represent means ± SEM, *adjusted p < 0.05, n = 6).
(B and C) Microphotographs show pAKT levels in OMN (B) and SC MN (C) cultures at D7 toxicity assay assessed by immunohistochemistry,
pAKT staining alone in small insets (red channel).
(D and F) Fluorescence intensities (D), analyzed in a semi-quantitative manner, indicate higher expression of pAKT in OMNs (F) (bar and
whiskers represent means ± SEM, two-way ANOVA and Tukey’s multiple comparison test, F(1, 353) = 66.1, ***p < 0.0001, n = 4). Scale bar
in (F), 60 mm (applies also to B and C).
(E and G) b-CATENIN expression is maintained in OMN also during kainate toxicity (E). (G) Semi-quantitative analysis of b-CATENIN over
NF200 staining intensities in OMNs and SC MNs in kainate conditions (bar and whiskers represent means ± SEM, t test, t = 6.799, df = 69,
***p < 0.0001, n = 3). Scale bar in (E), 60 mm.an elevated expression of Akt1 and Akt3 in oculomotor
neurons compared with spinal motor neurons (adjusted
p < 0.05, Figure 3A). Consistent with our RNA-sequencing
findings, immunocytochemistry against pAKT and quanti-
fication of fluorescent intensities in ISLET1/2+ oculomotor
and spinal motor neurons derived from mESCs demon-
strated that oculomotor neurons had higher levels of
pAKT protein than spinal motor neurons (Figures 3B–
3D). These levels were maintained after excitotoxicity eli-
cited by kainic acid (two-way ANOVA, ***p < 0.0001;
Figure 3D).
To further validate this pathway in oculomotor neuron
resistance, we analyzed the protein levels of activated
b-CATENIN (non-phosphorylated), a downstream effector
of AKT signaling, using immunocytochemistry (Figures 3E
and 3F). The semi-quantitative analysis demonstrated that
oculomotor neurons had elevated levels of b-CATENIN
compared to spinal cord motor neurons (two-way
ANOVA, ***p < 0.0001; Figure 3G). b-CATENIN expression
wasmaintained at relatively high levels in oculomotor neu-
rons compared to spinalmotor neurons also during kainate
toxicity, with expression preferentially localized to pro-
cesses (Figures 3F and 3G).Our data thus indicate that AKT signaling, which is a
known survival pathway, could contribute to oculomotor
neuron resistance in mouse in vivo as well as in a dish.
AKT Signaling Is Elevated in Human Postmortem
Oculomotor Neurons
To evaluate whether our in vitro data recapitulate motor
neuron resistance in human, we used the spatial transcrip-
tomics method LCM-seq (laser-capture microdissection
coupled with RNA sequencing) (Nichterwitz et al., 2016,
2018) to analyze individually isolated oculomotor neurons
(Figures S4A–S4D) and spinal motor neurons (cervical and
lumbar spinal cord) (Figures S4E–S4H) from human post-
mortem tissues. In addition, we isolated motor neurons
from the Onuf’s nucleus in the sacral spinal cord (Figures
S4I–S4L and Table S2), as these are highly resilient to degen-
eration in ALS and maintained until end stage of disease
(Mannen et al., 1977), similar to oculomotor neurons.
Analysis of marker gene expression showed that all motor
neuron groups expressed high levels of neurofilaments
and VACHT (SLC18A3) (Figure S4M). Motor neurons also
expressed ISL1/2 and ChAT, while being almost devoid of
contaminating glial markers, e.g., SLC1A3, AQP4, CCL3,Stem Cell Reports j Vol. 12 j 1329–1341 j June 11, 2019 1335
AIF1, SOX10, and MOG (Figure S4M). Analysis of the
PHOX2A/B andHOX gene code expression clearly clustered
oculomotor neurons away from all spinal motor neuron
groups (Figure S4N). PCA of all expressed genes separated
oculomotor neurons and spinal motor neurons along
PC2, while Onuf’s nucleus motor neurons separated out
on PC3 (Figure 4A). Analysis of the PI3K-AKT signaling
pathway (Figure S4O) demonstrated that AKT3 was
elevated in human oculomotor neurons (adjusted p <
0.05, Figure 4B), similar to mESC-derived oculomotor neu-
rons (Figure 3A). To analyze whether oculomotor and
Onuf’s motor neurons shared gene expression that was
distinct from other spinal motor neurons (cervical and
lumbar), we analyzed DEGs of oculomotor versus spinal
and Onuf’s versus spinal (Table S3). This analysis showed
that the majority of DEGs were unique to each cell type,
with 1,025 DEGs unique to oculomotor (553 up- and 472
downregulated compared to other spinal motor neurons)
and 921 DEGs unique to Onuf’s motor neurons (349 up-
and 572 downregulated compared to other spinal motor
neurons) (Figure 4C and Table S3). High AKT3 levels were
unique to oculomotor neurons. Elevated PVALB (parvalbu-
min) and GABRA1 levels were also unique to oculomotor
neurons (Figure 4C), consistent with previous findings
(Brockington et al., 2013; Comley et al., 2015; Hedlund
et al., 2010). Oculomotor and Onuf’s shared 214 DEGs, of
which 58 were upregulated and 142 downregulated
compared to other spinal motor neurons, and 14 of which
were regulated in the opposite direction in the two nuclei
(Figure 4C and Table S3). MIF (macrophage migration
inhibitory factor), which is neuroprotective in ALS (Shvil
et al., 2018), showed shared elevated expression in both oc-
ulomotor and Onuf’s motor neurons (Figure 4C). Gene
ontology (GO)-term analysis of the identified DEGs re-
vealed a number of GO terms that were upregulated in
oculomotor neurons versus the other motor neuron
groups, including gluconeogenesis, regulation of mem-
brane potential, anterograde transsynaptic signaling,
cation transmembrane transport, neurodevelopment,
neuron differentiation, and CNS development (Figure 4D
and Table S4). Analysis of GO terms enriched in Onuf’s
motor neurons included synaptic signaling, anterograde,
transsynaptic signaling, NAD biosynthetic process, ATP
biosynthetic process, regulated exocytosis, regulation of
neurotransmitter levels, and synaptic vesicle localization
(Figure 4E and Table S4).
In conclusion, our data indicate that AKT signaling is
elevated also in adult human oculomotor neurons and
may in part underlie their resilience to degeneration in
ALS. Notably, while oculomotor and Onuf’s nucleus motor
neurons mainly show distinct gene regulation, we also
identified common pathways that may underlie their joint
resilience.1336 Stem Cell Reports j Vol. 12 j 1329–1341 j June 11, 2019DISCUSSION
In ALS, motor neuron subpopulations show differential
vulnerability to degeneration. In particular, cranial motor
neurons of the oculomotor, trochlear, and abducens nuclei
(cranial nerves 3, 4, and 6), which innervate the extraocular
muscles around the eyes, are highly resistant throughout
disease progression. In our study we demonstrate that a
high proportion of bona fide oculomotor neurons can be
generated from mESCs through temporal overexpression
of PHOX2A, and that these are relatively resilient to ALS-
like toxicity.
Oculomotor neurons are generated in the ventral
midbrain through the specification by SHH (secreted
from the floor plate and the notochord), FGF8, and WNTs
(both secreted by and around the isthmic organizer).
These morphogens in turn regulate transcription factors
that influence differentiation of ventral midbrain neurons,
including oculomotor neurons, dopamine neurons, red
nucleus neurons, and GABA-positive interneurons (re-
viewed in Nijssen et al., 2017). Oculomotor neurons are
specified by the transcription factors PHOX2A, PHOX2B,
and LMX1B (Deng et al., 2011; Pattyn et al., 1997).
PHOX2A is required to drive oculomotor neuron fate as
demonstrated by the lack of both oculomotor and trochlear
nuclei in Phox2a knockout mice (Pattyn et al., 1997).
PHOX2A is also sufficient to generate a complete oculomo-
tor complex as shown by studies in chick (Hasan et al.,
2010; Pattyn et al., 1997). PHOX2B, on the other hand, is
sufficient to induce ectopic generation of oculomotor neu-
rons in the spinal cord, but is not required to induce oculo-
motor neuron specification in the midbrain (Dubreuil
et al., 2000; Pattyn et al., 1997). In vitro studies have shown
that (1) mESCs can be directly programmed into cranial
neurons using the proneuronal geneNgn2, in combination
with Islet1 and Phox2a (Mazzoni et al., 2013), and (2) over-
expression of either PHOX2A or PHOX2B alone in mESC-
derived neural progenitors exposed to SHH and FGF8 can
promote a midbrain/hindbrain motor neuron fate (Mong
et al., 2014). However, while it was demonstrated that
cranial motor neurons were generated in vitro it was never
previously determined whether oculomotor neurons were
specifically produced.
Here, we show that PHOX2A overexpression in neural
progenitors in combination with patterning using FGF8
and SHH resulted in the generation of 50% ISLET+ neurons
of which more than half were PHOX2A+. The transcrip-
tome and proteome of oculomotor neurons is distinct
from other motor neurons (reviewed in Nijssen et al.,
2017). Notably, oculomotor neurons can be distinguished
by their lack of the transcription factor HB9, which
defines other somatic motor neurons (Guidato et al.,
A B
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Figure 4. Human Oculomotor Neurons Show a Transcriptional Profile, with Elevated AKT3, Unique from Onuf’s Nucleus Motor
Neurons
(A) PCA of all expressed genes separated into Onuf’s, oculomotor (OMN), and spinal (cervical and lumbar) (SC_MN) motor neuron groups.
(B) RNA-sequencing data showed that AKT3 was elevated in OMNs compared to the other motor neuron groups (*adjusted p < 0.05, OMN
n = 8, SC_MN n = 12, Onuf’s n = 3, bar and whiskers represent means ± SEM).
(C) To distinguish the number of DEGs that were shared or unique to each resistant neuron group compared to vulnerable spinal motor
neurons, we analyzed DEGs between OMN and SC_MN and between Onuf’s and SC_MN. This analysis showed that the majority of DEGs were
unique to each resistant motor neuron group, with OMNs showing 553 upregulated and 472 downregulated unique DEGs and Onuf’s motor
neurons showing 349 upregulated and 572 downregulated unique DEGs. Oculomotor and Onuf’s shared 58 upregulated and 142 down-
regulated DEGs compared with vulnerable spinal motor neurons. *14 DEGs were regulated in the opposite direction in the two motor nuclei.2003; Lance-Jones et al., 2012). As the vast majority of
ISLET+ cells in our midbrain cultures lacked HB9, we
conclude that the PHOX2A+ cells generated were indeedoculomotor neurons and that Phox2a overexpression
is sufficient to induce an oculomotor fate from stem cells
in vitro. This conclusion was further supported by ourStem Cell Reports j Vol. 12 j 1329–1341 j June 11, 2019 1337
RNA-sequencing experiments on purified oculomotor and
spinal motor neuron cultures and our bioinformatics cross-
comparison with other in vitro and in vivo datasets from ro-
dent and man (Brockington et al., 2013; Hedlund et al.,
2010; Kaplan et al., 2014), which confirmed that the oculo-
motor neurons we generated were molecularly similar to
their in vivo counterpart. Furthermore, our analysis of
axon guidancemolecules demonstrated differential expres-
sion of distinct morphological markers in oculomotor and
spinal motor neurons. Finally, the electrical properties of
themESC-derivedmotor neuronsmatured over time in cul-
ture, and cells also expressed the cholinergic marker ChAT.
Altogether this demonstrates that we can generate bona
fide oculomotor neurons.
Furthermore, we found that mRNAs of Fgf10 and Fgf15
were enriched in our oculomotor cultures. These two mor-
phogens are normally expressed in the developing
midbrain, and Fgf10 is even present within oculomotor
neurons themselves (Hattori et al., 1997; Partanen, 2007).
It is therefore highly conceivable that these factors are
involved in further specifying the cultures. We therefore
believe that these factors can be used to further improve
the in vitro differentiation protocol, but this remains to be
further investigated.
Multiple studies have demonstrated that differential
motor neuron vulnerability appears to be regulated by
cell-intrinsic differences in gene expression (Allodi et al.,
2016; Brockington et al., 2013; Hedlund et al., 2010; Kaplan
et al., 2014). We therefore hypothesized that in vitro-
generated oculomotor neurons would be more resilient to
ALS-like toxicity than spinal motor neurons. Indeed, our
experiments on neuronal vulnerability clearly demon-
strated that oculomotor neurons were more resistant to
the ALS-like toxicity elicited by kainic acid than spinal
motor neurons. Furthermore, the fact that oculomotor
neuron processes remained intact indicates that these cells
were indeed highly resilient, as axonal degeneration is an
early sign of pathology in ALS.
It has been shown that oculomotor neuronshave ahigher
calcium-bufferingcapacity thanothermotorneurongroups
(Vanselow and Keller, 2000), which could render the cells
more resilient to excitotoxic insults.Ourfinding that several
transcripts with implications for calcium handling were
preferentially expressed in stem cell-derived oculomotor
neurons as well as oculomotor neurons in man were thus
very compelling and consistent with their resilience.
ESYT1, for example, is an ER integral membrane protein
that presents a cytosolic synaptotagmin-like domain that
can bind organelle membranes and a C2 domain able to
bind theplasmamembrane. These interactions are involved
in exchange of lipids and vesicles but also, in the ER, control
of Ca2+ homeostasis. Thus, ER-plasmamembrane junctions
can control Ca2+ release fromER in response to extracellular1338 Stem Cell Reports j Vol. 12 j 1329–1341 j June 11, 2019Ca2+ levels (Giordano et al., 2013), an event that could have
a beneficial effect during excitotoxicity.
Furthermore, we have previously shown that AKT
signaling plays an important role in induced resistance in
vulnerable motor neurons (Allodi et al., 2016). We now
demonstrate that Akt signaling is more highly activated in
resistant oculomotor neurons in vitro aswell as in vivo in hu-
man oculomotor neurons. This observation indicates that
oculomotor neurons preferentially activate a cell-intrinsic
survival program. Notably, cross-comparison of human oc-
ulomotor neurons with resilient human Onuf’s nucleus
motor neurons showed that elevated AKT signaling was
unique to oculomotor neurons. When comparing human
oculomotor andOnuf’smotor neuronswith vulnerable spi-
nal motor neurons it became evident that the majority of
DEGswere unique to each resilient nucleus. However, there
were commonly regulated genes across these two resilient
nuclei, including MIF. MIF was recently shown to inhibit
the toxicity of misfolded SOD1 (Shvil et al., 2018), indi-
cating that these two neuron groups may be better at
handling toxic aggregation-prone proteins.
In conclusion, we have demonstrated that bona fide oc-
ulomotor neurons can be generated from stem cells
in vitro.We also show that these neurons are relatively resil-
ient to ALS-like toxicity. This finding enables modeling of
neuronal resistance and susceptibility in ALS in vitro, which
could further elucidate mechanisms that could be highly
advantageous to activate in vivo to rescue vulnerable motor
neurons from degeneration.EXPERIMENTAL PROCEDURES
Ethics Statement
All work was carried out according to the Code of Ethics of the
World Medical Association (Declaration of Helsinki) and with na-
tional legislation and institutional guidelines. Animal procedures
were approved by the Swedish animal ethics review board (Stock-
holm Norra Djurfo¨rso¨ksetiska Na¨mnd). Ethical approval for the
use of the human post mortem samples was obtained from the
regional ethical review board in Stockholm, Sweden (Regionala
Etikpro¨vningsna¨mnden, Stockholm, EPN). Human CNS samples
were obtained from the Netherlands Brain Bank (www.
brainbank.nl), the National Disease Research Interchange (www.
ndriresource.org), and the NIH Neurobiobank with the written
informed consent from the donors or next of kin.
Generation of mESC Lines and Specification into
Oculomotor and Spinal Motor Neurons
Three different mESC lines were used in this study: E14.1 (ATCC),
Hb9-GFP (gift from Dr. S. Thams, Karolinska Institutet), and Islet1-
GFP (gift fromProf. S. Pfaff, UCSD). To increase oculomotor neuron
differentiation efficiency, we generated E14.1/NesEPhox2a and
Islet1-GFP/NesEPhox2a mESC lines by Lipofectamine (Invitrogen)
transfection. NesEPhox2a construct was a gift from Prof. J. Ericson
(Karolinska Institutet). As the nestin enhancer was used for overex-
pression, transgene overexpression is limited to neuronal progeni-
tors. Specification of mESCs into spinal motor neurons was
conducted by exposing embryo bodies (EBs) to the smoothened
agonist SAG (500 nM, Calbiochem #364590-63-6) and retinoic
acid (100 nM,Calbiochem#302-79-4) for 5 days, while oculomotor
neurons were patterned by SAG (250 nM) and FGF8 (100 ng/mL,
R&DSystems #423-F8) for 5 days.Mediumcontainingmorphogens
was replaced daily. EB dissociation andmotor neuron culturemain-
tenance were carried out as previously described (Wichterle et al.,
2002). Oculomotor neurons and spinal motor neurons were kept
in Neurobasal medium + Glutamax (Gibco) with a cocktail of tro-
phic factors (5 ng/mL each of glial cell line-derived neurotrophic
factor, brain-derived neurotrophic factor, neurotrophin-3, and
ciliary neurotrophic factor). All cultures, including survival experi-
ments, were treated with themitotic inhibitor 5-fluoro-20-deoxyur-
idine (final concentration 2 mM) to reduce cell proliferation.Fluorescent-Activated Cell Sorting and RNA
Sequencing of Stem Cell-Derived Neurons
Islet1-GFP/NesEPhox2a and Hb9-GFP ESCs were differentiated into
oculomotor and spinal motor neurons, respectively. GFP+ motor
neurons were sorted, and positive and negative fractions were
collected for mRNA sequencing or plated for subsequent immuno-
cytochemistry analysis. FACS was performed using a 100-mm
nozzle, a sheath pressure of 15–25 pounds per square inch and
an acquisition rate of 1,000–2,000 events per second (Hedlund
et al., 2008). 5 3 103 cells were collected in 5% Triton X-100
(Sigma-Aldrich) in water and then prepared for RNA-seq as previ-
ously described (Nichterwitz et al., 2016). Samples were sequenced
on Illumina HiSeq2000 and HiSeq2500 platforms with read
lengths of 43 and 51 bp, respectively.Laser-Capture Microdissection and RNA Sequencing
of Human Motor Neurons
LCM-seq of motor neurons from human postmortem tissues was
performed as previously described (Nichterwitz et al., 2016, 2018).RNA-Seq Data Processing
Reads from cell-culture samples were mapped to the mouse mm10
reference genome with HISAT2 (Kim et al., 2015) using the pub-
licly available infrastructure (available at usegalaxy.org) on the
main Galaxy server (Afgan et al., 2016). Human LCM samples
were mapped to hg38/GRCh38 (Gencode version V29) using
STAR version 2.5.3 (Dobin et al., 2013). Transcript-level counts
and RPKMvalueswere obtained using rpkmforgenes.py (Ramskold
et al., 2009). After mapping, the basic exclusion criteria were
<500,000 mapped reads and, for LCM samples, lack of both motor
neuron marker transcripts ISL1 and ChAT.ALS-like Toxicity and Motor Neuron Survival
Oculomotor and spinalmotor neurons were cultured for 5 days and
thenexposed tokainicacid.Threeconcentrationsofkainicacidwere
tested: 20, 50, and 100 mM. A concentration of 20 mM was found
sufficient to induceconsistentmotorneurondeathalsowhenmotor
neurons were cultured on astrocytes. Kainate toxicity was inducedfor 7 days. Quantifications were performed blind to the motor
neuron population and toxicity condition. Pictures were taken
with a Zeiss LSM700 confocal microscope (403magnification and
1.5 digital zoom)using theZEN2010S SP1 software and then further
analyzedby ImageJ software.At least fourexperimentsper condition
were quantified in technical duplicates. Twelve random areas were
quantified per each coverslip (at least 130 cells were quantified for
each condition). To evaluate proliferation and generation of motor
neurons, we exposed cultures to pulses of BrdU (Sigma #B5002) for
24 h. BrdU was dissolved in dimethyl sulfoxide (DMSO; Sigma
#276855) and added to the cultures at a final concentration of
10 mM. After 24 h of exposure to BrdU, cells were washed twice
with fresh culture medium. Proliferation was assessed at day
0 (D0), day 2 (D2), and day 3 (D3) of the survival protocol and all
samples were fixedwith 4% paraformaldehyde at day 7 (D7). Quan-
tifications were performed in triplicates with technical duplicates.Morphological Analysis
Arborization and Sholl analysis were conducted utilizing Fiji soft-
ware. To compare arborization area of oculomotor neurons and
spinal motor neurons, we transformed the microphotographs to
a grayscale 8-bit image, and assessed quantification after applying
a threshold for signal intensity/background correction. Threshold
values were kept constant among images, and microphotographs
with higher background noise were excluded. Between 10 and 12
pictures per condition per experiment were quantified. Experi-
ments were performed in quadruplicates. The complexity of oculo-
motor neuron arborization after kainic acid toxicity was obtained
by Sholl analysis (O’Neill et al., 2015) by calculating the average
of neurites intersecting defined concentric cycles spaced 25 mm
from each other starting from the center of the cell body as a func-
tion of distance from soma. Individual oculomotor neurons were
analyzed after culturing them at lower density (spinal motor
neuron analysis could not be performed due to their poor survival
at lower densities). Several microphotographs were taken at 403
magnification with a Zeiss LSM700 confocalmicroscope,mounted
with Adobe Photoshop software, and analyzed with Fiji software.
The intersection averages were analyzed by multiple t test.Statistical Analysis
All statistical analyses were performedwithGraphPad software un-
less otherwise specified. Two-way ANOVA was used when taking
into accountmultiple variables andmakingmultiple comparisons,
followed by appropriate post hoc analysis. Unpaired Student’s t
test was used to compare two groups. Further details on statistical
tests used can be found in figure legends as well as information on
the total number of motor neurons counted per experiment. All
experimentswere performed at least in triplicatewith technical du-
plicates. All results are expressed as mean ± SEM unless otherwise
specified.
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